JANE STREET GROUP, LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 64 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 1.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$32,601
-41.1%
13,992
-39.9%
0.00%
Q2 2023$55,371
-68.6%
23,265
-75.7%
0.00%
Q1 2023$176,412
+330.3%
95,876
+397.1%
0.00%
Q3 2022$41,000
-2.4%
19,289
+31.1%
0.00%
Q2 2022$42,000
-39.1%
14,717
+10.2%
0.00%
Q4 2021$69,000
-64.8%
13,352
-54.9%
0.00%
Q2 2021$196,000
-10.1%
29,588
+117.7%
0.00%
Q2 2020$218,00013,5900.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,300,000$17,160,0002.55%
Alphabet Inc. 699,352$9,231,0000.56%
DAFNA Capital Management LLC 100,000$1,320,0000.45%
JUPITER ASSET MANAGEMENT LTD 705,356$9,311,0000.29%
Artal Group S.A. 500,000$6,600,0000.26%
Cormorant Asset Management, LP 479,988$6,336,0000.25%
MPM BioImpact LLC 39,740$525,0000.19%
Granahan Investment Management 305,158$4,028,0000.18%
Burrage Capital Management LLC 13,113$173,0000.12%
Vident Investment Advisory, LLC 118,866$1,569,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders